Keyphrases
Cardiogenic Shock
100%
Acute Myocardial Infarction
64%
Out-of-hospital Cardiac Arrest
47%
30-day Mortality
19%
Impella
16%
Cardiac Arrest
15%
Randomized Clinical Trial
14%
AmiC
14%
Blood Pressure Target
13%
Refractory Cardiogenic Shock
13%
Porcine Model
13%
Confidence Interval
12%
Shock Patient
10%
Neuron-specific Enolase
10%
Percutaneous Coronary Intervention
9%
Comatose Survivors
9%
Right Ventricular Function
9%
Myocardial Infarction
9%
Severe Disabilities
9%
Mean Arterial Pressure
9%
Heart Rate
8%
Impella RP
8%
Tocilizumab
8%
Hazard Ratio
8%
Cerebral Performance Category
8%
Oxygenation Targets
7%
Intensive Care
7%
Left Ventricular Ejection Fraction
7%
Montreal Cognitive Assessment (MoCA)
7%
Coma
7%
High-score
7%
Mechanical Circulatory Support
7%
Revascularization
6%
Left Ventricular Function
6%
Cardiac Index
6%
Comatose Patients
5%
Diabetes
5%
Right Ventricle
5%
Treatment Effect
5%
End-organ Perfusion
5%
Brain Injury
5%
Inflammation
5%
Myocardial Injury
5%
Randomized Controlled Trial
5%
Inflammatory Response
5%
Left Ventricular Dysfunction
5%
Denmark
5%
Vasopressors
5%
Prognostic Importance
5%
Placebo-controlled
5%
Medicine and Dentistry
Cardiogenic Shock
82%
Acute Heart Infarction
47%
Out of Hospital Cardiac Arrest
29%
Heart Arrest
16%
Blood Pressure
15%
Noradrenalin
13%
Montreal Cognitive Assessment
11%
Coma
11%
Percutaneous Coronary Intervention
11%
Hazard Ratio
11%
Revascularization
11%
Hemodynamic
10%
Mean Arterial Pressure
9%
Myocardial Infarction
9%
Modified Rankin Scale
8%
Neuron Specific Enolase
8%
Lactic Acid
8%
Intensive Care
8%
Heart Failure
7%
Assisted Circulation
7%
Apoplexy
6%
Heart Left Ventricle Ejection Fraction
6%
Randomized Controlled Trial
5%
Right Ventricle
5%
Adverse Event
5%
Cognitive Function
5%
Randomized Clinical Trial
5%
Stroke Volume
5%
Diabetes
5%
Shock (Circulatory)
5%
Heart Left Ventricle Failure
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiogenic Shock
74%
Out of Hospital Cardiac Arrest
41%
Acute Heart Infarction
41%
Heart Arrest
15%
Neuron Specific Enolase
13%
Coma
11%
Heart Infarction
11%
Randomized Clinical Trial
10%
Biological Marker
8%
Rankin Scale
8%
Porcine Model
8%
Noradrenalin
6%
Epinephrine
6%
Placebo
6%
Adverse Event
5%
Inflammation
5%
Lactic Acid
5%
Brain Injury
5%
